Amphista Therapeutics
Cambridge
About Amphista Therapeutics
Amphista Therapeutics operates as a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $60.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2022)
- Website: amphista.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/amphista-therapeutics-41524 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.